REDUCTION IN MIGRAINE-ASSOCIATED BURDEN OVER 24 WEEKS OF TREATMENT WITH EPTINEZUMAB IN PATIENTS WITH CHRONIC MIGRAINE

VALUE IN HEALTH(2022)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要